Bibliografia - 3ª Parte

501. CROXATTO, H.B., ORTIZ, M.E., and VALDEZ, E. IUD mechanisms of action. In: In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 44–62.

502. DALING, J.R., WEISS, N.S., VOIGHT, L.F. MCKNIGHT, B., and MOORE, D.E. The intrauterine device and primary tubal infertility. [Letter] New England Journal of Medicine 326(3): 203–204. Jan. 16, 1992.

503. DIAZ, J., BAHAMONDES, L., DIAZ M. MARCHI, N., FAUNDES, A., and MARINI, M. Evaluation of the performance of the Copper T380A IUD up to ten years. Is this IUD a reversible but potentially permanent method? Advances in Contraception 8: 275–280. 1992.

504. DIAZ, J., FAUNDES, A., DIAZ, M., and MARCHI, N. Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil. Contraception 47: 169–175. 1993.

505. DIAZ, J., PINTO NETO, A., DIAZ, M., MARCHI, N.M., and BAHAMONDES, L. Long-term evaluation of the clinical performance of the TCu200B and the TCu380A in Campinas, Brazil. Advances in Contraception 8: 67–72. 1992.

506. EGYPT. NATIONAL POPULATION COUNCIL (NPC), and DEMOGRAPHIC AND HEALTH SURVEYS. MACRO INTERNATIONAL. Egypt Demographic and Health Survey 1992: Preliminary Report. Columbia, Maryland, NPC and DHS, Mar. 1993. 25 p.

* 507. FARLEY, T.M.M., ROSENBERG, M.J., ROWE, P.J., CHEN, J.H., and MEIRIK, O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339: 785–788. Mar. 28, 1992.

508. FARR, G., and RIVERA, R. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: Analysis of TCu-380A acceptors in developing countries. American Journal of Obstetrics and Gynecology 167(1): 144–151. Jul. 1992

509. FAUNDES, A., ALVAREZ, F., BRACHE, V., and TEJADA, A.S. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation. International Journal of Gynecology and Obstetrics 26: 429–433. 1988.

510. FINGER, W.R. Today’s IUDs offer safe, effective contraception. Network 13(3): 12–15. Mar. 1993.

511. FOREIT, K.G., FOREIT, J.R., LAGOS, G., and GUZMAN, A. Effectiveness and cost-effectiveness of postpartum IUD insertion in Lima, Peru. International Family Planning Perspectives 19(1): 19–24. Mar. 1993.

512. GOMMAA, H.I. Effects of contraceptive counseling on mother’s acceptance, continuation rate and side effects of I.U.D. and pill. Summary. 1991. 11 p. (Unpublished)

513. GRIMES, D.A., and SCHULZ, K.F. Prophylactic antibiotics at IUD insertion. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 164–170.

514. GUPTA, B.K., GUPTA, A.N. and LYALL, S. Return of fertility in various types of IUD users. International Journal of Fertility 34 (2): 123–125. 1989.

515. HACETEPPE UNIVERSITY. INSTITUTE OF POPULATION STUDIES. 1988 Turkish Population and Health Survey. Ankara, Haceteppe University, Apr. 1989. 173 p.

516. HO, J., WU, Z., CAI, S. HAN, J., LIU, M., HU, S., and LUI, Z. A randomized comparative trial of the MLCu375, TCu220C, Steel Ring, and Uterine Cavity-Shaped IUDs. Advances in Contraception 8: 161–166. 1992.

517. INDIAN COUNCIL OF MEDICAL RESEARCH. TASK FORCE ON IUD. Randomized clinical trail with intrauterine devices (levonorgestrel intrauterine device (LNG), CUT 380Ag, CuT 220C and CuT 200B). Contraception 39(1): 37–52. 1989.

518. JORDAN. MINISTRY OF HEALTH (MOH). and INSTITUTE FOR RESOURCE DEVELOPMENT (IRD). Jordan Population and Family Health Survey 1990. Amman, Jordan. and Columbia, Maryland, MOH. and IRD, 1992.

519. JOVANOVIC, R., BARONE, C.M., VAN NATTA, F.C., and CONGEMA, E. Preventing infection relating to insertion of an intrauterine device. Journal of Reproductive Medicine 33(4): 347–352. Apr. 1988.

520. KAHN, J.G., WALKER, C.K., WASHINGTON, A.E., LANDERS, D.V., and SWEET, R.L. Diagnosing pelvic inflammatory disease: Developing a new model. Journal of the American Medical Association 266(18): 2594–2604. Nov. 13, 1991.

521. KESSEL, E. Pelvic inflammatory disease with intrauterine device use: A reassessment. Fertility and Sterility 51(1): 1–11. Jan. 1989.

522. KURZ, K.H. and MEIER-OEHLKE, P.A. The CU SAFE 300 IUD, a new concept in intrauterine contraception: First year results of a large study with follow-up of 1017 acceptors. Advances in Contraception 7(2–3): 291–300. Jun.-Sep. 1991.

523. LADIPO, O.A., FARR,G., OTOLORIN, E., KONJE, J.C., STURGEN, K., COX, P., and CHAMPION, C.B. Prevention of IUD-related pelvic infection: The efficacy of prophylactic doxycycline at IUD insertion. Advances in Contraception 7(1): 43–54. Mar. 1991.

524. LARA, R., SANCHEZ, R.A., and AZNAR, R. Aplicacion del dispositivo intrauterino a traves de la incision de la cesarea. [IUD insertion during cesarean section.][SPA] Ginecologia y Obstetricia de Mexico 57: 23–27. Jan. 1989.

525. LARSSON, B. and WENNERGREN, M. Investigation of a copper-intrauterine device (Cu-IUD) for possible effect on frequency and healing of pelvic inflammatory disease. Contraception 15: 143–149. 1977.

526. LASSISE, D.L. SAVITZ, D.A., HAMMAN, R.F., BARON, A.E., BRINTON, L.A., and LEVINES, R.S. Invasive cervical cancer and intrauterine device use. International Journal of Epidemiology 20(4): 865–870. 1991.

527. LAZARIN, A., SARACCO, A., MUSICCO, M., and NICOLOSI, A. Man-to-woman sexual transmission of the human immunodeficiency virus: Risk factors related to sexual behavior, man’s infectiousness, and woman’s susceptibility. Archives of Internal Medicine 151: 2411–2416. Dec. 1991.

* 528. LEE, N.C., RUBIN, G.L., and BORUCKI, R. The intrauterine device and pelvic inflammatory disease revisited: New results from the Women’s Health Study. Obstetrics and Gynecology 72(1): 1–6. Jul. 1988.

529. LOVESET, T. A comparative evaluation of the Multiload 250 and Multiload 375 intra-uterine devices. Acta Obstetrica Gynecologica Scandinavica 69: 521–526. 1990.

530. LUUKKAINEN, T. Progestin-releasing intrauterine contraceptive device. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 32–41.

531. LUUKKAINEN, T., LAHTEENMAKI, P, and TOIVONEN, J. Levonorgestrel-releasing intrauterine device. Annals of Medicine 22: 85–90. 1990.

532. MEIRIK, O. Infection in non-pregnant women: incidence and risk factors in the 1980s and 1990s. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 142–150.

533. MORENO, L. and GOLDMAN, N. Contraceptive failure rates in developing countries: evidence from the Demographic and Health Surveys. International Family Planning Perspectives 17(2): 44–49. 1991.

534. MOROCCO. MINISTERE DE LA SANTE PUBLIQUE SECRETARIAT GENERAL (MSPSG). DIVISION DE LA PLANIFICATION DE LA STATISTIQUE ET DE L’INFORMATIQUE. SERVICE DES ETUDES ET DE L’INFORMATION SANITAIRE. and DEMOGRAPHIC AND HEALTH SURVEYS (DHS). MACRO INTERNATIONAL. Enquete national sur la population et al santé Maroc 1992; Rapport préliminaire. [National survey on population and health, Morocco 1992.][FRE] Columbia, Maryland, MSPSG. and DHS, no date.

535. O’HANLEY, K. and HUBER, D.H. Postpartum IUDs: Keys for success. Contraception 45: 351–361. 1992.

536. PAP-AKESON, M., SOLHEIM, F., THORBERT, G., WILHELMSSON, L., and AKERLUND, M. Inserting IUD threads together with the device into the uterine cavity reduces the incidence of genital tract infections. British Journal of Family Planning 15: 11–14. Apr. 1989.

537. PETERSON, H.B., WALKER, C.K., KAHN, J.G., WASHINGTON, A.E., ESCHENBACH, DE.A., and FARO, S. Pelvic inflammatory disease: Key treatment issues and options. Journal of the American Medical Association 266(18): 2605–2611. Nov. 13, 1991.

538. POTTS, D.M., CHAMPION, C.B., KOZUH-NOVAK, M., ALVAREZ-SANCHEZ, F., SANTISO-GALVEZ, R., TACLA, X., COHEN, J., and RIVERA, R. IUDs and PID: A comparative trial of strings versus stringless devices. Advances in Contraception 7: 231–240. 1991.

539. SANDMIRE, H.F. Fertility after intrauterine device discontinuation. Advances in Contraception 2: 327–335. 1986.

540. SASTRAWINATA, S., FARR, G., PRIHADI, S.M., HUTAPEA, H., ANWAR, M., WAHYUDI, I., SUNJOTO, KEMARA, K.P., CHAMPION, C.B., and ROBBINS, M. A comparative clinical trial of the TCu 380A, Lippes Loop D, and Multiload Cu 375 IUDs in Indonesia. Contraception 44 (2): 141–154. Aug. 1991.

541. SAYED, A.-A.H., OSMAN, MI., EL-ZANATY, F. and WAY, A.A. Egypt Demographic and Health Survey 1988. Cairo. and Columbia, Maryland, Egypt National Population Council. and Institute for Resource Development/Macro Systems, Oct. 1989. 250 p.

542. SINEI, S.K.A., SCHULZ, K.F., LAMPTEY, P.R., GRIMES, D.A., MATI, J.K.G., ROSENTHAL, M.J., RIARA, G., NJAGE, P.N., BHULLAR, V.B., and OGEMBO, H.V. Preventing IUCD-related pelvic infection: The efficacy of prophylactic doxycycline at insertion. British Journal of Obstetrics and Gynaecology 97: 412–419. May 1990.

543. SIVIN, I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstetrics and Gynecology 78(2): 291–298. Aug. 1991.

544. SIVIN, I. IUDs are contraceptives, not abortifacients: A comment on research and belief. Studies in Family Planning 20(6): 355–359. 1989.

545. SIVIN, I. Should collared Copper T intrauterine devices be replaced before eight years? British Journal of Family Planning 18: 9–11. 1992.

546. SIVIN, I., EL MAHGOUB, S., MCCARTHY, T., MISHELL, D.R., SHOUPE, D. ALVAREZ, F., BRACHE, V., JIMENEZ, E., DIAZ, J., FAUNDES, A., DIAZ, M.M., COUTINHO, E., MATTOS, C.E.R., DIAZ, S.L. PAVEZ, M., and STERN, J. Long-term contraception with the Levonorgestrel 20 mcg/day (LNg 20) and the Copper T 380Ag intrauterine devices: A five-year randomized study. Contraception 42(4): 361–378. Oct. 1990.

547. SIVIN, I., GREENSLADE, F., SCHMIDT, F, and WALDMAN, S.N. The Copper T 380 intrauterine device: A summary of scientific data. New York, Population Council, 1992.

548. SIVIN, I., SHAABAN, M, ODLIND, V., OLSSON, S.-E., DIAZ, S., PAVEZ, M. ALVAREZ, F., BRACHE, V., and DIAZ, J. A randomized trial of the Gyne T and Gyne T Slimline intrauterine copper devices. Contraception 42(4): 379–389. 1990.

549. SIVIN, I., STERN, J., COUTINHO, E., et al. Prolonged intrauterine contraception: a seven-year randomized study of the Levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDs. Contraception 44(5): 473–480. Nov. 1991.

550. SIVIN, I., STERN, J., DIAZ, S., PAVEZ, M, ALVAREZ, F., BRACHE, V., MISHELL, D.R., LACARRA, M., MACCARTHY, T., HOLMA, P, DARNEY, P., KLAISLE, C., OLSSON, S.-E., and ODLIND, V. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel- releasing or copper TCu 380Ag intrauterine contraceptive devices. American Journal of Obstetrics and Gynecology 166(4): 1208–1213. Apr. 1992.

* 551. SKJELDESTAD, F.E. Conception rates post-IUD removal. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 63–75.

552. SKJELDESTAD, F., and BRATT, H. Fertility after complicated and non- complicated use of IUDs. A controlled prospective study. Advances in Contraception 4(3): 179–184. Sep. 1988.

553. SOEPRONO, R. Return to fertility after discontinuation of copper IUD use: A study of 55 pregnancies involving Multiload Cu-250 users among private patients in Indonesia. Advances in Contraception 4(2): 95–107. Jun. 1988.

554. TEISALA, K. Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease. Annals of Medicine 21: 63–65. 1989.

555. THIERY, M. Contraception for post-partum use: non hormonal methodsintrauterine devices. Presented at the International Conference on Postpartum Contraception, Mexico City, Sep. 1990.

556. TOIVONEN, J., LUUKKAINEN, T., and ALLONEN, H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: Three years’ comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstetrics & Gynecology 77(2): 261–264. Feb. 1991.

557. UNITED KINGDOM FAMILY PLANNING RESEARCH NETWORK. Pregnancy outcome associated with use of IUDs. British Journal of Family Planning 15: 7–10. 1989.

558. UNITED STATES. DEPARTMENT OF HEALTH AND HUMAN SERVICES. CENTERS FOR DISEASE CONTROL (CDC). Pelvic inflammatory disease: Guidelines for prevention and management. Morbidity and Mortality Weekly Report 40(RR5): 1–25. Apr. 26, 1991.

559. UNITED STATES. DEPARTMENT OF HEALTH AND HUMAN SERVICES. CENTERS FOR DISEASE CONTROL (CDC). 1993 Sexually Transmitted Diseases Treatment Guidelines. Jan. 8, 1993. 111 p. (Unpublished)

560. VAN DIERENDONCK, B., LADIPO, O.A., EKWEMPU, C.C., GIWA-OSAGIE, O.F., and ULASI, J.N. A multicenter clinical trial in Nigeria with Multiload-Cu250 (MLCu250) and Multiload-Cu375 (MLCu375) intrauterine devices. Advances in Contraception 8: 327–330. 1992.

561. VAN KETS, H., PAREWIJCK, W., KLEINHOUT, J., ZIGHELBOIM, I., OSLER, M., and TATUM, H.J. Clinical experience with the GYNE-T 380 postpartum intrauterine device. Fertility and Sterility 55 (6): 1144–1149. Jun. 1991.

562. WANG, S.L., WU, S.C., XIN, X.M., CHEN, J.H., and GAI, J. Three years’ experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: A randomized comparative study. Advances in Contraception 8: 105–114. 1992.

563. WILDEMEERSCH, D., VAN DER PAS, H., THIERY, M., VAN KETS, H., PAREWIJICK, W., and DELBARGE, W. The Copper-Fix (Cu-Fix): A new concept in IUD technology. Advances in Contraception 4(3): 197–205. Sep. 1988.

* 564. WILSON, J.C. A New Zealand randomized comparative study of three IUDs (Nova T, MLCu375, MLAgCu250): 1-, 2- and 3-year results. Advances in Contraception 8: 153–159. 1992.

565. WORLD HEALTH ORGANIZATION (WHO). Improving access to quality care in family planning: Medical eligibility criteria for initiating and continuing use of contraceptive methods. Geneva, WHO, 1996.

566. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. TASK FORCE ON THE SAFETY AND EFFICACY OF FERTILITY REGULATING METHODS. The TCu380A, TCu220C, Multiload 250 and Nova T IUDs at 3, 5, and 7 years of use—Results from three randomized multicentre trials. Contraception 42(2): 141–158. Aug. 1990.

567. XU, J.-X., CONNELL, C., and CHI., I.-C. Immediate postpartum intrauterine device insertionA report on the Chinese experience. Advances in Contraception 8: 281–290. 1992.

568. YEMEN. CENTRAL STATISTICAL ORGANIZATION (CSO). PAN ARAB PROJECT FOR CHILD DEVELOPMENT (PAPCD). and DEMOGRAPHIC AND HEALTH SURVEYS (DHS). MACRO INTERNATIONAL. Yemen Demographic and Maternal and Child Health Survey 1991–92: Preliminary Report. Columbia, Maryland, CSO, PAPCD, and DHS, Sep. 1992. 22 p.

569. ZHANG, J., FELDBLUM, P.J., CHI, I.C., and FARR, M.G. Risk factors for Copper T IUD expulsion: An epidemiological analysis. Contraception 46: 427–433. 1992.

Referencias mas Recientes

570. ANONYMOUS. China to ban unreliable IUD. People and the Planet 2(4): 1993.

571. AJELLO, C., LIMPAPHAYOM, K., GAFFIKIN, L., LUMBIGANON, P., and MCGRATH, J. A humanistic approach to IUD clinical training: Results of a comparative study in Thailand. Baltimore, Johns Hopkins Program for International Education in Reproductive Health, Dec. 1994. (Technical Report FCA-04) 18 p.

572. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS. The intrauterine device: ACOG Technical Bulletin Number 164 Feb. 1992 (Replaces ACOG Technical Bulletin Number 104, May 1987). International Journal of Gynecology and Obstetrics 41(2): 189–193. May 1993.

573. ANDERSON, K., ODLINK, V., and RYBO, G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 49(1): 56–72. Jan. 1994.

574. ANGLE, M.A., BROWN, L.A., and BUEKENS, P. IUD protocols for international training. Studies in Family Planning 24(2): 125–131. Mar.-Apr. 1993.

* 575. BARDIN, C.W. and MISHELL, D.R., Jr., eds. Proceedings from the Fourth International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. 341 p.

576. BASUKI, B., ROSSING, M.A., and DALING, J.R. Intrauterine device use and risk of tubal pregnancy: An Indonesian case-control study. International Journal of Epidemiology 723(5): 1000–1005. Oct. 1994.

577. BATÁI., KUUKANKORPI, A., SILJANDER, M., and RAURAMO, I. One year clinical experience with Nova T 380 IUD. [Abstract, 14th FIGO World Congress at Montreal, Canada 1994] International Journal of Gynecology and Obstetrics 46(Suppl. 2): 79. Sep. 1994.

578. CASTELLSAGUE, X., THOMPSON, W.D., and DUBROW, R. Intra-uterine contraception and the risk of endometrial cancer. International Journal of Cancer 54(6): 911–916. Jul. 30, 1993.

579. CHI, I.-C. A bill of health for the IUD: Where do we go from here? Advances in Contraception 10(2): 121–131. Jun. 1994.

580. CHOW, W.H., DALING, J.R., WEISS, N.S., MOORE, D.E., SODERSTROM, R.M., and METCH, B.J. IUD use and subsequent tubal ectopic pregnancy. American Journal of Public Health 76(5): 536–539. May 1986.

581. CIMBER, H. Sof-T. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth- Heinemann, 1994. p. 338–341.

582. COSTE, J., JOB-SPIRA, N., FERNANDEZ, H., PAPIERNIK, E., and SPIRA, A. Risk factors for ectopic pregnancy: A case-control study in France, with special focus on infectious factors. American Journal of Epidemiology 133(9): May 1, 1991.

583. DIAZ, J., PINTO NETO, A.M., BAHAMONDES, L., DIAZ, M., ARCE, X.E., and CASTRO, S. Performance of the Copper T 200 in parous adolescents: Are copper IUDs suitable for these women? Contraception 48(1): 23–28. Jul. 1993.

584. DO T.H., HOANG T.V., DONALDSON, P.J., and QUAN L. The pattern of IUD use in Vietnam. International Family Planning Perspectives 21(1): 6–10. Mar.-Apr. 1995.

585. ENTWISLE, B., KOZYREVA, P., ZOHOORI, N., and CROSS, C. Family planning and abortion in the Russian Federation: The Russian Longitudinal Monitoring Survey 1992–94. Chapel Hill, North Carolina, University of North Carolina at Chapel Hill, Mar. 1995. 16 p.

586. ESCHENBACH, D.A. Earth, motherhood, and the intrauterine device. Fertility and Sterility 57(6): 1177–1179. Jun. 1992.

587. FAMILY HEALTH INTERNATIONAL (FHI). Intrauterine devices (IUDs). [Loose-leaf binder and inserts] Research Triangle Park, North Carolina, FHI, 1995. (Contraceptive Technology Update Series)

588. FANDES, A., ALVAREZ, F., and D AZ, J. A Latin American experience with levonorgestrel IUD. Annals of Medicine 25(2): 149–153. Apr. 1993.

589. FANDES, A. Women deserve accurate information. Network 16(2): 4–5. Winter 1996.

590. FEI PRODUCTS (FEI). Patient information: Copper T model TCu 380A brand intrauterine copper contraceptive. [Package insert][ENG, FRE, SPA, ARA] N. Tonawanda, New York, FEI, Jul. 1995. 2 p.

591. FEI PRODUCTS (FEI). Prescribing information: Copper T model TCu 380A brand of intrauterine copper contraceptive. [Package insert][ENG, FRE, SPA, ARA] N. Tonawanda, New York, FEI, Jul. 1995. 2 p.

592. FINGER, W.R. IUD insertion timing vital in postpartum use. Network 16(2): 21–22, 24. Winter 1996.

593. FINGER, W.R. Proper IUD use requires training. Network 16(2): 6–10. Winter 1996.

* 594. FORREST, J.D. and FORDYCE, R.R. Women’s contraceptive attitudes and use in 1992. Family Planning Perspectives 25(4): 175–179. Jul.-Aug. 1993.

595. GRIMES, D.A. The intrauterine device, pelvic inflammatory disease, and infertility: The confusion between hypothesis and knowledge. Fertility and Sterility 58(4): 670–673. Oct. 1992.

596. HARLAP, S., KOST, K., and FORREST, J.D. Preventing pregnancy, protecting health: A new look at birth control choices in the United States. New York, Alan Guttmacher Institute, 1991. 128 p.

597. HATCHER, R.A., RINEHART, W., BLACKBURN, R.D., and GELLER, J.S. Essentials of contraceptive technology. Baltimore, Johns Hopkins School of Public Health, Population Information Program, 1996. (Forthcoming)

598. INTERNATIONAL INSTITUTE FOR POPULATION SCIENCES (IIPS). National Family Health Survey (MCH and Family Planning), India 1992–93. Bombay, IIPS, 1995. 402 p.

599. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). INTERNATIONAL MEDICAL ADVISORY PANEL. Statement on contraception for clients who are HIV positive. London, IPPF, Nov. 1991. 3 p.

600. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). INTERNATIONAL MEDICAL ADVISORY PANEL. Statement on intrauterine devices. London, IPPF, Oct. 1995. 8 p.

* 601. JANOWITZ, B., HUBACHER, D., PETRICK, T., and DIGHE, N. Should the recommended number of IUD revisits be reduced? Studies in Family Planning 25(6): 362–367. Nov.-Dec. 1994.

602. KALANDIDI, A., DOULGERAKIS, M., TZONOU, A., HSIEH, C.-C., ARAVANDINOS, D., and TRICHOPOULOS, D. Induced abortions, contraceptive practices, and tobacco smoking as risk factors for ectopic pregnancy in Athens, Greece. British Journal of Obstetrics and Gynaecology 98(2): 207–213. Feb. 1991.

603. KAUFMAN, J. The cost of IUD failure in China. Studies in Family Planning 24(3): 194–196. May-Jun. 1993.

604. KINCAID, D.L., YUN, S.H., PIOTROW, P.T., and YASER, Y. Turkey’s mass media family planning campaign. In: Backer, T.E. and Rogers, E.M., eds. Organizational aspects of health communication campaigns: What works? Newbury, California, Sage, 1993. p. 68–92.

605. LEONARD, A.H. and LADIPO, O.A. Postabortion family planning: Factors in individual choice of contraceptive methods. Advances in Abortion Care 4(2): 1–4. 1994.

606. LIN, C.C. and HUANG, M. Taiwan’s national family planning program. In: International Fertility Research Program. Surgical family planning methods: The role of the private physician. Research Triangle Park, North Carolina, 1981. p. 15–41.

607. LURIE, S., KATZ, Z., YECHEZKELI, Y., LIFSCITZ-MERCER, B., and SHOHAM, Z. Microscopic salpingitis is not an etiologic factor of tubal pregnancy with intrauterine devices. International Journal of Fertility 39(6): 333–336. Nov.-Dec. 1994.

608. LUUKKAINEN, T. (Family Health International) [Postpartum insertion of T IUDs] Personal communication, Dec. 5, 1995.

609. LUUKKAINEN, T. The levonorgestrel-releasing IUD. British Journal of Family Planning 19(3): 221–224. Oct. 1993.

* 610. LUUKKAINEN, T. and TOIVONEN, J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 52(5): 269–276. Nov. 1995.

611. MACRO INTERNATIONAL (MI). DEMOGRAPHIC AND HEALTH SURVEYS. and REPUBLIC OF KAZAKSTAN. NATIONAL ACADEMY OF SCIENCES (NAS). INSTITUTE OF NUTRITION. Kazakstan Demographic and Health Survey 1995: Preliminary report. Calverton, Maryland. and [Alma-Ata], Kazakstan, MI. and NAS, Sep. 1995.

612. MARCHBANKS, P.A., ANNEGERS, J.F, COULAM, C.B., STRATHY, J.H., and KURLAND, L.I. Risk factors for ectopic pregnancy: A population-based study. Journal of the American Medical Association 259(12): 1823–1827. Mar. 25, 1988.

613. MATI, J.K.G., HUNTER, D.J., MAGGWA, B.N., and TUKEI, P.M. Contraceptive use and risk of HIV infection in Nairobi, Kenya. International Journal of Gynecology and Obstetrics 48(1): 61–67. Jan. 1995.

* 614. MCINTOSH, N., KINZIE, B., and BLOUSE, A., eds. IUD guidelines for family planning service programs: A problem-solving reference manual. 2nd ed. Baltimore, Johns Hopkins Program for International Education in Reproductive Health, 1993.

615. MILSOM, I., ANDERSSON, K., JONASSON, K., LINDSTEDT, G., and RYBO, G. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status. Contraception 52(3): 175–179. Sep. 1995.

616. MUSICCO, M., NICOLOSI, A., SARACCO, A., and LAZZARIN, A. IUD use and man to woman sexual transmission of HIV-1. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 179–188.

617. PARAZZINI, F., LA VECCHIA, C., and MORONI, S. Intrauterine device use and risk of endometrial cancer. British Journal of Cancer 70(4): 672–673. Oct. 1994.

618. PETERSEN, K.R., BROOKS, L., JACOBSEN, B., and SKOUKY, S.O. Intrauterine devices in nulliparous women. Advances in Contraception 7(4): 333–338. 1991.

619. PETTA, C.A., AMATYA, R., FARR, G., and CHI, I.-C. An analysis of the personal reasons for discontinuing IUD use. Contraception 50(4): 339–347. Oct. 1994.

620. POPULATION COUNCIL (PC). Copper T 380A intrauterine device is effective for 10 years. [News release] New York, PC, Sep. 27, 1994. 3 p.

621. ROB, A.K.U., CERNADA, G.P., SIDDIQUI, K.A., and NAEEM, J. Pakistan IUD follow-up survey: 1992–93. Islamabad, Pakistan, Population Council. and Pakistan. Ministry of Population Welfare, 1993. 62 p.

622. ROBEY, B., RUTSTEIN, S.O., MORRIS, L., and BLACKBURN, R. The reproductive revolution: New survey findings. Population Reports, Series M, No. 11. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Dec. 1992. 44 p.

623. ROSSING, M.A., DALING, J.R., VOIGT, L.F., STERGACHIS, A.S., and WEISS, N.S. Current use of an intrauterine device and risk of tubal pregnancy. Epidemiology 4(3): 252–258. May 1993.

624. ROSSING, M.A., DALING, J.R., WEISS, N.S., VOIGT, L.F., STERGACHIS, A.S., WANG, S.-P., and GRAYSTON, J.T. Past use of an intrauterine device and risk of tubal pregnancy. Epidemiology 4: 245–251. May 1993.

* 625. ROWE, P.J. Research on intrauterine devices. In: World Health Organization (WHO). Special Programme of Research, Development and Research Training in Human Reproduction. Annual technical report: 1992. Geneva, WHO, 1993. 289 p.

626. SCHMIDT, F., SIVIN, I., and WALDMAN, S. The Copper T 380 IUD. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 298–307.

627. SIVIN, I. Another look at the Dalkon Shield: Meta-analysis underscores its problems. Contraception 48(1): 1–12. Jul. 1993.

* 628. SIVIN, I. Extrauterine pregnancies and intrauterine devices reassessed. In: Bardin, C.W. and Mishell, D.R., Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 195–209.

629. SIVIN, I. IUDs and HIV: An editorial comment on the Italian Partner Study. In: Bardin, C.W. and Mishell, D.R. Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 189–192.

630. SIVIN, I. and STERN, J. Health during prolonged use of levonorgestrel 20 g/d and the copper TCu 380Ag intrauterine contraceptive devices: A multicenter study. Fertility and Sterility 61(1): 70–77. Jan. 1994.

631. SKJELDESTAD, F.E. Conception rates post IUD removal. In: Bardin, C.W. and Mishell, D.R., Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 63–75.

632. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. China changes from the stainless steel ring to modern IUDs. Progress 27: 7. 1993.

633. STANBACK, J., OMONDI-ODHIAMBO, and OMUODO, D. Why has IUD use slowed in Kenya? Part A: Qualitative assessment of IUD service delivery in Kenya. Final report. Aug. 1995. 48 p. (Unpublished)

* 634. TECHNICAL GUIDANCE WORKING GROUP (TGWG). Recommendations for updating selected practices in contraceptive use: Results of a technical meeting: 1. Combined oral contraceptives progestin-only injectables Norplant implants copper-bearing intrauterine devices.

* 635. TIETJEN, L., CRONIN, W., and MCINTOSH, N. Infection prevention for family planning service programs: A problem-solving reference manual. Durant, Oklahoma, Essential Medical Information Systems, 1992.

636. TINKER, A. and KOBLINSKY, M.A. Making motherhood safe. Washington, D.C., World Bank, 1993. (World Bank Discussion Paper No. 202) 143 p.

637. TREIMAN, K. and LISKIN, L. IUDs—A new look. Population Reports, Series B, No. 5. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Mar. 1988. 32 p.

638. TRUSSELL, J. (Office of Population Research, Princeton University). [Annual chances of pregnancy.] Personal communication, Dec. 17, 1995. 2 p.

639. TRUSSELL, J., HATCHER, R.A., CATES, W., STEWART, F.H., and KOST, K. Contraceptive failure in the United States: An update. Studies in Family Planning 21(1): 51–54. 1990.

640. UNITED NATIONS (UN). DEPARTMENT FOR ECONOMIC AND SOCIAL INFORMATION AND POLICY ANALYSIS. World contraceptive use 1994. [Wallchart] New York, UN, 1994. 2 p.

641. VAN KETS, H., VRIJENS, M., VAN TRAPPEN, Y., et al. The frameless GyneFix intrauterine implant: A major improvement in efficacy, expulsion and tolerance. Advances in Contraception 11(2): 131–142. Jun. 1995.

642. VAN KETS, H., WILDEMEERSCH, D., VAN DER PAS, H., et al. IUD expulsion solved with implant technology. Contraception 51(2): 87–92. Feb. 1995.

643. VAN KETS, H.E., VAN DER PAS, H., DELBARGE, W., and THIERY, M. A randomized comparative study of the TCu 380A and Cu-Safe 300 IUDs. Advances in Contraception 11(2): 123–129. 1995.

644. WALSH, T.L., BERNSTEIN, G.S., GRIMES, D.A., FREZIERES, R., BERNSTEIN, L., and COULSON, A.H. Effect of prophylactic antibiotics on morbidity associated with IUD insertion: Results of a pilot randomized controlled trial. Contraception 50(4): 319–327. Oct. 1994.

645. WEISS, N.S., DALING, J.R., and CHOW, W.H. Control defiition in case-control studies of ectopic pregnancy. American Journal of Public Health 75(1): 67–68. Jan. 1985.

646. WESTHOFF, C. Past intrauterine device use and risk of tubal pregnancy. [Letter] Epidemiology 5(1): 129–130.

647. WILDEMEERSCH, D. The FlexiGard 330. In: Bardin, C.W. and Mishell, D.R., Jr., eds. Proceedings from the 4th International Conference on IUDs. Boston, Butterworth-Heinemann, 1994. p. 273–283.

648. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. A randomized multicentre trial of the Multiload 375 and TCu380A IUDs in parous women: Three-year results. Contraception 49(6): 543–549. Jun. 1994.

649. WORLD HEALTH ORGANIZATION. SPECIAL PROGRAMME OF RESEARCH, DEVELOPMENT AND RESEARCH TRAINING IN HUMAN REPRODUCTION. The TCu 380A IUD and the frameless IUD "the FlexiGard": Interim three-year data from an international multicenter trial. Contraception 52(2): 77–83. Aug. 1995.

650. XU, J.-X., REUSCHÉ., and BURDAN, A. Immediate postplacental insertion of the intrauterine device: A review of Chinese and the world’s experiences. Advances in Contraception 10(1): 71–82. Mar. 1994.

651. XU X., BUEKENS, P., and WOLLAST, E. IUD use and the risk of ectopic pregnancy: A meta-analysis of case-control studies. Contraception 52(1): 23–34. Jul. 1995.

Addenda

652. ASOCIACIÓEMOGRÁA SALVADOREÑA (ADS). National Family Health Survey: FESAL-93. [Encuesta Nacional de Salud Familiar: FESAL-93.][SPA] San Salvador, El Salvador, ADS, Apr. 1994. 428 p.

653. GUTIÉZ, M., OCHOA, L.H., and RAGGERS, H. Bolivia: National Demographic and Health Survey 1994. [Bolivia: Encuesta Nacional de Demografía y Salud 1994.][SPA] La Paz, Bolivia. and Calverton, Maryland, República de Bolivia. National Statistics Institute. and Macro International, Oct. 1994. 286 p.

654. LISKIN, L. Sexually transmitted diseases: Syndromic and laboratory diagnosis, treatment, and follow-up. [Wall chart] In: Lande, R. Controlling sexually transmitted diseases. Population Reports, Series L, No. 9. Baltimore, Johns Hopkins School of Public Health, Population Information Program, Jun. 1993. 2 p.

655. MCINTOSH, N., BLOUSE, A., and SCHAEFER, L. Norplant implants guidelines for family planning service programs: A problem-solving reference manual. 2nd ed. Baltimore, Johns Hopkins Program for International Education in Reproductive Health, 1995.

656. MCINTOSH, N., TIETJEN, L., POTTS, J., and WILSON, T., 3rd. A practical method for high-level disinfection of surgical gloves. [Abstract] Presented at the 122nd Annual Meeting of the American Public Health Association, Washington, D.C., Oct. 30-Nov. 3, 1994.

ISSN 0887-0276

Population Reports is published by the Population Information Program, Center for Communication Programs, The Johns Hopkins School of Public Health, 111 Market Place, Suite 310, Baltimore, Maryland 21202-4012, USA

Palavras chave: iud, international, intrauterine, diaz, contraception, 1992 , j, health, population, mar, device, m, jr, journal, contraception 8:, diaz m marchi, advances contraception, m marchi, cut, diaz m,